Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.77 |
| ▸ | GAA | P10253 | 3/20 | 0.77 |
| ▸ | POLB | P06746 | 1/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | ESR1 | P03372 | 5/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | JAK2 | O60674 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392731 | 1.00 | KMT2A (0.77) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL3757751 | 0.90 | KMT2A (0.70) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL30185780 | 0.89 | HSD17B10 (0.67) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL8367791 | 0.88 | KMT2A (0.78) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL27773732 | 0.87 | KMT2A (1.00) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL11754236 | 0.86 | KMT2A (0.76) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL11358096 | 0.83 | KMT2A (0.62) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| Acetic Acid SCHEMBL27380873 | 0.83 | KMT2A (0.62) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL10686808 | 0.82 | HSD17B10 (0.71) | KMT2AGAAPOLBHSD17B10ALDH1A1 | |
| SCHEMBL3635482 | 0.82 | HPGD (0.76) | KMT2AGAAPOLBHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2230 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| US-11648198-B2 | Expandable gastroretentive dosage form | CLEXIO BIOSCIENCES LTD. (IL) | 2023-05-16 | — | — | US | claimed |
| CN-115607556-A | Medicine for preventing and treating asthma, chronic obstructive pulmonary disease, allergic diseases, etc | 刘力 | 2023-01-17 | — | — | CN | claimed |
| CN-115607516-A | Medicine for preventing and treating cold or viral diseases | 刘力 | 2023-01-17 | — | — | CN | claimed |
| WO-2021054927-A2 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-03-25 | — | — | WO | claimed |
| EP-3263145-B1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | BECTON DICKINSON CO (US) | 2021-01-20 | — | — | EP | claimed |
| US-20200405635-A1 | EXPANDABLE GASTRORETENTIVE DOSAGE FORM | CLEXIO BIOSCIENCES LTD. (IL) | 2020-12-31 | — | — | US | claimed |
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2020-02-13 | — | — | US | claimed |
| EP-2822532-B1 | AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE | COVESTRO DEUTSCHLAND AG (DE) | 2018-09-19 | — | — | EP | claimed |
| US-9872941-B2 | Antimicrobial compositions and methods for locking catheters | BECTON, DICKINSON AND COMPANY (US) | 2018-01-23 | — | — | US | claimed |
| WO-1998020864-A9 | USE OF SELECTED NON-STEROIDAL ANTIINFLAMMATORY COMPOUNDS FOR THE PREVENTION AND THE TREATMENT OF NEURODEGENERATIVE DISEASES | — | 1998-08-27 | — | — | WO | claimed |
| WO-1998020864-A2 | USE OF SELECTED NON-STEROIDAL ANTIINFLAMMATORY COMPOUNDS FOR THE PREVENTION AND THE TREATMENT OF NEURODEGENERATIVE DISEASES | UNIVERSITA' DEGLI STUDI DI BRESCIA - DIPARTIMENTO DI SCIENZE BIOMEDICHE (IT) | 1998-05-22 | — | — | WO | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| US-5536419-A | Procedure for extraction of polyhydroxyalkanoates from halophilic bacteria which contain them | REPSOL QUIMICA S.A. (ES) | 1996-07-16 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0622462-A1 | Procedure for the extraction of polyhydroxyalkanoates from halophilic bacteria which contain them | REPSOL QUIMICA S.A. (ES) | 1994-11-02 | — | — | EP | claimed |
| US-4432966-A | SUSTAINED RELEASE | ROUSSEL-UCLAF (FR) | 1984-02-21 | — | — | US | claimed |